Rituximab is an anti-CD20 monoclonal antibody that is administered systemically in combination with chemotherapy, but can also be given intrathecally.
How is rituximab administered?
Rituximab is given in hospital, through a drip into a vein. This is known as an intravenous infusion. This is done by a doctor or nurse, so they can monitor you for any side effects while you’re taking rituximab. The first infusion takes around six hours, but later infusions will take around two to four hours.
How do you give MabThera?
MabThera should be administered as two 500 mg IV infusions separated by two weeks, followed by a 500 mg IV infusion every 6 months thereafter. Patients should receive MabThera for at least 24 months after achievement of remission (absence of clinical signs and symptoms).
How do you reconstitute rituximab?
Withdraw the necessary amount of Rituxan and dilute to a final concentration of 1 to 4 mg/mL in an infusion bag containing either 0.9% Sodium Chloride, USP, or 5% Dextrose in Water, USP. Gently invert the bag to mix the solution. Do not mix or dilute with other drugs. Discard any unused portion left in the vial.
Does rituximab cross the blood brain barrier?
Rituximab may not traverse the normal blood–brain barrier (BBB) and this could limit the effectiveness of this agent in PCNSL. Rituximab concentrations in CSF are 0.1% of plasma levels when it is administered at a standard IV dose of 375 mg/m2, suggesting poor BBB penetration.
Where is Rituxan administered?
So instead of being taken as a pill or an injection, it is given as an infusion, which is a needle placed in a vein. Infusions are given by trained healthcare professionals. When you receive your Rituxan infusion, it will be given to you in combination with another medication called methotrexate.
Why Rituximab must be administered intravenously?
Intravenous Rituximab infusion is licensed to treat patients with severe life or organ threatening Vasculitis and used off licence for Systemic Lupus Erythematosus in conjunction with corticosteroids and primary glomerular disease such as Minimal Change and Membranous Nephropathy.
How do you give rituximab subcutaneously?
Subcutaneous injections: MabThera 1400 mg subcutaneous formulation should be administered as subcutaneous injection only, over approximately 5 minutes. The hypodermic injection needle must only be attached to the syringe immediately prior to administration to avoid potential needle clogging.
How do you store Rituxan?
Rituxan solutions for infusion may be stored at 2°C – 8°C (36°F – 46°F) for 24 hours. Rituxan solutions for infusion have been shown to be stable for an additional 24 hours at room temperature. However, since Rituxan solutions do not contain a preservative, diluted solutions should be stored refrigerated (2°C – 8°C).
What are the long term side effects of rituximab?
Does Rituxan cause any long-term side effects?
- heart problems, such as heart attack or ventricular fibrillation (a type of abnormal heart rhythm)
- blockage or tearing of your intestines.
- kidney failure or other serious kidney problems.
- serious infections, such as shingles.
- reactivation of the hepatitis B virus*
Does methotrexate cross blood brain barrier?
Infusion of high-dose intravenous methotrexate (MTX) has been demonstrating to penetrate the blood-brain barrier. The aim of this present study was to assess the efficacy and safety of high dose MTX in patients with central nervous system (CNS) metastases of breast cancer.
How often is RITUXAN administered?
Rituxan is typically given every 6 months, or based on your doctor’s evaluation of your symptoms. If your symptoms return before it’s time for your next course, you and your healthcare provider may decide to treat earlier (but no sooner than 4 months).
